The statistics are clear. Over the next decade optometric and ophthalmic practices in North America, Europe and throughout the developed world will identify and treat an increasing number of patients with diabetes and diabetic retinopathy (DR). There are currently more than 40 million people in North America with diabetes and that number is expected to grow to over 50 million by 2025.1 In Europe, the number of those afflicted with the disease—currently over 60 million – will also see significant growth.2 These trends present practitioners with real challenges – first, how to more efficiently screen this large and growing population for signs of DR, and second, how to provide more informed and effective treatment at all stages of the disease.
Many practitioners are rising to these challenges with the help of a technology that has unique, proven capabilities in improving DR diagnosis and management – ultra-widefield (UWF™) retinal imaging.
Ultra-widefield Retinal Imaging
UWF imaging is performed by a specially-designed scanning laser ophthalmoscope (SLO) that generates a high-resolution digital image which captures 200° (or about 82%) of the retina. Conventional techniques may image 45° or less of the retina. The SLO simultaneously scans using two low power lasers (red and green) that …